Summary of the “Fecal Worm Egg Count Reduction” Trials in Merck Animal Health National Data Base 2018 Donald H. Bliss1 Robert D. Moore2 William G. Kvasnicka3.

Slides:



Advertisements
Similar presentations
Bovine Nematode Resistance
Advertisements

MODELING ISOTOPES. PAGE 120 IN TEXTBOOK USE THE INFORMATION ON PAGE 120 TO WRITE THE PROCEDURE. REMEMBER TO FOLLOW CORRECT LAB REPORT FORMAT. SET UP THE.
Medical Reports HOW TO GET ALL OF THAT DATA YOU ENTERED BACK OUT AGAIN.
The Scottish Sheep Scab Initiative Presentation prepared by Brian Hosie SAC Veterinary Services, Edinburgh.
Lessons Learned Feeding Buffalo John Bowron DVM Prairie Heights Bison.
Goat Management.
Administering Medications. Pneumonia Soremouth Infectious Bovine Rhinotracheitis (IBR) Taken from InfoVets Cattle CD.
HEALTH MANAGEMENT OF SHOW FOOD ANIMALS Floron C. Faries, Jr., DVM, MS Texas Cooperative Extension College of Veterinary Medicine Texas A&M University.
Parasite Control and Rotational Grazing Patty Scharko, DVM, MPH Extension Ruminant Veterinarian Livestock Disease Diagnostic Center.
Novel Approaches to Control of Gastrointestinal Nematodes (GINs) in South American Camelids (SACs) Gillespie, R.M. RVT, BS*, Terrill. T.H., PhD*, Williamson,
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Comparative efficacy evaluation of Albendazole and Ivermectin drench formulation against internal parasites of donkeys in Sudan. SAWSAN M. A. IMAM (1,
Efficacy of pour-on dewormers on weight gain and fecal egg count in Hawaiian stocker cattle Jonathon Beckett 1, Tim Richards 2, Craig Reinemeyer 3 1 Animal.
Summarising Male Circumcision Efficacy: Results of the three randomised clinical trials Neil A Martinson Perinatal HIV Research Unit.
Agrosept. Effective but kind hand hygiene with unique long lasting effect Agrosept.
The incidence of parasitism in Midwest shelter owned companion animals Rachel Berkley, Shoshana Tanenbaum, Claudia J. Baldwin, DVM, MS; Richard B. Evans,
Criminal Justice Referral and Incentives in Outpatient Substance Abuse Treatment Anthony DeFulio 1, Paul Nuzzo 2, & Maxine Stitzer 1 1 – Johns Hopkins.
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 4 Gathering Data Section 4.3 Good and Poor Ways to Experiment.
Anthelmintics. Effective deworming program- small ruminants Deworm ewes shortly before, or right at, lambing. –best opportunity to disrupt the parasites'
Comparisons of shelter and foster housed companion animals in the Midwest Shoshana Tanenbaum, Rachel Berkley, Claudia J Baldwin, DVM, MS; Richard B. Evans,
Raymond F. Anton, MD for The COMBINE Study Research Group
© Mark E. Damon - All Rights Reserved Another Presentation © All rights Reserved
Bioavailability of cobalt and antihelmintic effects of Albendazole fortified with cobalt (Vermitan super) in sheep J.M.Nguta a ; J.M.Mbaria a Department.
ACT - TOPIC O-1 Running Laboratory Tests 1. 2 Laboratory Tests Laboratory testing aids in the diagnosis and treatment of sick animals. There are several.
How to write a scientific article Nikolaos P. Polyzos M.D. PhD.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Livestock Parasite Control Getting rid of the creepy crawlies!
Donald H. Bliss1 Robert D. Moore2 William G. Kvasnicka3
Anthelmintics Effective deworming program- small ruminants Deworm ewes shortly before, or right at, lambing. –best opportunity to disrupt the parasites'
Anthelmintics.
Background  Substance abusers are at risk for HIV and other STIs.  Anal intercourse (AI) is riskier than vaginal intercourse.  Studies of AI have focused.
Readiness To Change HIV/HCV Risk Behavior Among Young African American IDUs. Edward V Morse, PhD, Tulane University Health Sciences Center, Department.
October 24, 2006 Advisory Committee on Research on Women’s Health. 1 Summary Report of NIH Inclusion Data – FY2005 Carlos E. Caban, Ph.D., M.P.H. Office.
1 Clinical Studies Section of Labeling Joseph Porres, M.D., Ph.D. Medical Officer Division of Dermatologic and Dental Drug Products FDA.
Daniel J. Houlihan1, Maria E. Prado 1,2 and Sharon Patton3
Sam Womble County Extension Agent – Ag/NR Bexar County
Extra-genital samples for gonorrhoea and chlamydia in women and MSM Self-taken samples analysed separately compared with self-taken pooled samples Janet.
Parasite Control In Beef Cattle
Clinical Trials — A Closer Look
The DEPression in Visual Impairment Trial:
Lasers in Glaucoma: Meta analysis
Parasites – Ruminants.
Engagement and Treatment Completion in a Correctional Sample
STAC36 - March 2014 Design and Evaluation of a Health Educational Board Game for the Control of Soil Transmitted Helminthiasis among Primary School.
Feasibility of Shortening the Germination and Fluorescence Test Period
Fecal Egg Counts: A useful tool in parasite management
Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.
Peer Observations
Ascariasis.
Surveying the Safety of NOACs in the Real World
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Water Treatment Virtual Lab
Farm Size Trend.
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
AromaTouch Technique July 2017 Study Results
Administering Medications
Updates in Heart Failure:
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
The Role of the Private Vet
WORM TESTS We are measuring eggs – Not worms
Section 4-3 Relations in Categorical Data
Behavior Modification Report with Peak Reduction Component
Impulse = change of momentum
The Research Question Does changing prescription medication labels to conform to the United States Pharmacopeia (USP) patient-centered, more understandable,
Subhead Calibri 14pt, White
A new treatment has been discovered that is believed to be the cure for HIV/AIDS. Brainstorm possible ways to convince the general public that this is,
SYNOPSIS OF THE PROTOCOL
FLOWER SEED Germination Referee
FIGURE 1. Flowchart of PnCRM7 clinical trial participants, primary efficacy cohort, and sub-populations used for efficacy analyses. Clinical trial participants.
Don’t let internal parasites affect performance!
Presentation transcript:

Summary of the “Fecal Worm Egg Count Reduction” Trials in Merck Animal Health National Data Base 2018 Donald H. Bliss1 Robert D. Moore2 William G. Kvasnicka3 1MidAmerica Ag Research, Verona, WI 2College of Agriculture, Biotechnology & Natural Resources, University of Nevada 3University of Nevada, Professor Emeritus

Protocol for Fecal Worm Egg Count Reduction Test (FECRT) All clinics agreed to use a standard protocol: 20 samples taken at the time of treatment. 20 samples taken 14-days after treatment. Pre-/post-treatment samples sent to same lab: ● Treatment not revealed until test completed. ● Modified WI Sugar Flotation Technique (Eggs/3 g). ● Results sent to participating clinic and entered in Merck Animal Health National Database.

Fecal Egg Count Reduction Test Results (All Trials-2018) 250+ Participating Vet Clinics. 24+ States Represented. 721 Trials Completed. 24,186 Samples Analyzed. 12,171 Pre-treatment Samples. 12,015 Post-treatment Samples.

Table 1: Efficacy Summary for Fecal Egg Count Reduction Test Conducted with Macrocyclic Lactone Endecticide Pour-On Products (2009-2018). _________________________________________________________________ No. of No. of Egg Counts/3g* Percent Products Trials Samples Pre-Rx Post-Rx Efficacy(%) Pour-ons: Ivomec® PO 8 313 33.7 26.7 20.8% Ivermectin PO 29 1,284 67.5 36.6 45.9% Dectomax® PO 11 474 53.3 18.1 66.0% Cydectin® PO 12 517 55.4 15.4 72.2% Eprinex® PO 3 144 49.3 38.0 22.9% --------------------------------------------------------------------------------- PO Summary 63 2,732 57.6 28.1 51.0% _________________________________________________________________ *All samples taken at Rx and again 14-days post-Rx.

No. of No. of Egg Counts/3g* Percent Table 2: Efficacy Summary for Fecal Egg Count Reduction Test Conducted with Injectable Macrocylic Lactone Endecticide Products (2009-2018). __________________________________________________________________________________ No. of No. of Egg Counts/3g* Percent Products Trials Samples Pre-Rx Post-Rx Efficacy Injections: Ivomec® Inj. 16 988 64.9 35.8 44.8% Ivomec® Plus 22 900 101.4 54.1 46.6% Dectomax® Inj. 27 1,161 75.9 16.7 78.0% Cydectin Inj. 7 311 36.0 5.9 83.6% Ivermectin Inj. 10 506 90.7 55.0 39.4% LongRange 14 563 48.6 17.5 64.0% ------------------------------------------------------------------------------------------ Inj. Summary: 96 4,429 74.6 31.8 57.4% _____________________________________________________________ *All samples taken at Rx and again 14-days post-Rx.  

Table 3: Efficacy Summary for Fecal Egg Count Reduction Test Conducted with Various Safe-Guard® & Panacur® Formulations (2018). ______________________________________________________________________________________ No of No of Egg Counts/3g* Percent Products Trials Samples Pre-Rx Post-Rx Efficacy Panacur® Drench 32 1,296 59.3 0.7 98.8% SG Drench/Paste 71 2,979 65.0 0.8 98.7% Summary-Drench 103 4,275 63.2 0.8 98.7% ------------------------------------------------------------------------------------ SG Feed 25 1,297 45.6 0.1 99.7% SG 1.96% 19 803 38.6 0.7 98.1% SG Mineral 8 306 36.6 1.5 95.9% Liquid Feed/cubes blocks/Paste 20 835 38.1 1.6 95.8% ------------------------------------------------------------------------------------ Overall Summary 175 7,516 53.9 0.7** 98.7% ________________________________________________________________ All samples taken at Rx and again 14-days post-Rx ** Note: Coccidia prevalence was reduced by 56.5%.

Table 4: Efficacy Summary for Fecal Egg Count Reduction Test Conducted with Safe-Guard®/Panacur® in Combination with Various Endecticide Formulations (2018). _____________________________________________________________________________________ Combination No of No of Egg Counts/3g Percent Product Trials Samples Pre-Rx Post-Rx Efficacy -------------------------------------------------------------------------------------------------------Safe-Guard® or Panacur ® plus: Ivomec® Inj./plus/PO 21 805 79.4 0.4 99.4% Ivermectin PO/Inj. 34 1,424 81.3 1.1 98.6% Dectomax® Inj./PO 7 223 83.4 0.1 99.8% Cydectin PO 8 320 40.0 0.2 98.6% ---------------------------------------------------------------------- Combination 70 2,772 76.2 0.7* 99.1% Summary _______________________________________________________ Note: Coccidia prevalence was reduced by 76.9%

Table 5: Efficacy Summary for Fecal Egg Count Reduction Test Conducted for all Products (2009-2018). ______________________________________________________________________________________ Number of Number of Egg Counts/3g** Percent Products Trials Samples Pre-Rx Post-Rx Efficacy(%) Endecticide Injectable: 96 4,429 74.6 31.8 57.4% Pour-On: 63 2,732 57.6 28.1 51.0% Safe-Guard® /Panacur® 175 7,516 53.9 0.7 98.7% Combination Treatment*** 70 2,772 76.2 0.7 99.1% ______________________________________________________________________ *All samples taken at Rx and 14-days post-Rx. ** Safe-Guard® plus an Endecticide.

Table 6: Comparison of FECRT Efficacy for ML Pour-Ons 2008(AABP) vs Products No. of Trials Percent No. of Trials Percent Efficacy 2008 Efficacy 2009-2015 Efficacy Change --------------------------------------------------------------------------------------------------------- Ivomec® 8 72.3% 8 20.8% - 51.5% Ivermectin 35 59.7% 29 45.9% - 13.8% Dectomax® 8 78.9% 11 66.0% - 12.9% Cydectin® 9 67.2% 12 72.2% + 5.0% Eprinex® 0 3 22.9% ---------------------------------------------------------------------------- Summary 60 66.1% 63 51.0% - 15.1% Updated 2018

Table 7: Comparison of FECRT Efficacy ML Injectables: 2008(AABP) vs Products No. of Trials Percent No. of Trials Percent Efficacy 2008 Efficacy 2009-2015 Efficacy Change ----------------------------------------------------------------------------------------------- Ivomec® Inj. 6 76.2% 16 44.8% - 31.4% Ivomec® Plus 6 42.6% 22 46.6% + 4.3% Ivermectin Inj. 1 50.0% 10 41.4% - 8.6% Dectomax® 11 90.5% 27 76.3% - 14.2% Cydectin® 2 98.1% 7 83.6% -14.5% LongRange --- ------- 14 64.0% ----- ---------------------------------------------------------------------------- Summary 26 72.5% 96 57.4% -15.1%